Back

Ernexa Therapeutics appoints Robert J. Spiegel to board of directors

Verifying
  • Ernexa Therapeutics appointed Robert J. Spiegel to its board.
  • Robert J. Spiegel, M.D., FACP, was identified as a biopharmaceutical executive.
  • The announcement concerns Ernexa Therapeutics’ board of directors.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.